Ionis Pharmaceuticals, Inc. (IONS) promotes Eric E. Swayze to senior vice president of research and appoints C. Frank Bennett to chief scientific officer

Ionis Pharmaceuticals, Inc. (IONS) promotes Eric E. Swayze to senior vice president of research and appoints C. Frank Bennett to chief scientific officer

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) has grown 1.30% during the last 3-month period. Year-to-Date the firm performance stands at 18.26%. On Tuesday, Ionis Pharmaceuticals moved -2.05% down and closed at the price of $63.93, after opening at $65.20. The total volume of shares exchanged was 1.21 million. The company’s total market capitalization stands at $8.87 billion, along with 138.81 million outstanding shares. Ionis Pharmaceuticals, Inc. (Particles) today revealed the arrangements of C. Forthcoming Bennett, Ph.D., as…

Read More